Emmanuel Itti

发表

Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images

Yann Cointepas, Pierre Payoux, Georges El Fakhri, 2007, Journal of Nuclear Medicine.

Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study

John O. Prior, John O Prior, Emmanuel Itti, 2018, PloS one.

Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

Pierre Vera, Emmanuel Itti, Romain Modzelewski, 2017, The Journal of Nuclear Medicine.

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Emmanuel Itti, Michel Meignan, Felix Reyes, 2005, Blood.

Lymph node imaging: basic principles.

Emmanuel Itti, Michel Meignan, Alain Luciani, 2006, European journal of radiology.

Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis

Emmanuel Itti, Michel Meignan, Alain Luciani, 2007, Journal of Nuclear Medicine.

Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma

Alexandre Vignaud, Pierre Brugières, Emmanuel Itti, 2010, European Radiology.

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients

Federica Fioroni, Annibale Versari, Emmanuel Itti, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Changes in cerebral metabolism are detected prior to perfusion changes in early HIV‐CMC: A coregistered 1H MRS and SPECT study

Laurent Itti, Linda Chang, Emmanuel Itti, 2000, Journal of magnetic resonance imaging : JMRI.

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Rachida Lebtahi, Mohamed Bouattour, Christophe Aubé, 2017, The Lancet. Oncology.

Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot Study

Emmanuel Itti, Michel Meignan, Alain Luciani, 2011, Investigative radiology.

Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma

Emmanuel Itti, Michel Meignan, Alain Luciani, 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.